Luciano Costa, MD, PhD | Authors

Luciano Costa, MD, PhD, Shares Key Takeaways From the MASTER Trial in Multiple Myeloma

October 19, 2021

CancerNetwork® sat down with Luciano Costa, MD, PhD, at the 2021 International Myeloma Workshop to discuss the benefit of treatment with daratumumab, carfilzomib, lenalidomide, and dexamethasone and the population of patients with newly diagnosed myeloma who will best benefit from treatment.